Literature DB >> 11841890

Vasopressin and epinephrine are equally effective for CPR in a rat asphyxia model.

S Kono1, H Bito, A Suzuki, Y Obata, H Igarashi, S Sato.   

Abstract

Epinephrine has been administered as a drug essential for cardiopulmonary resuscitation (CPR). Recently, vasopressin has been reported to be more effective than epinephrine for CPR in a ventricular fibrillation (VF) model. As a different myocardial pathology is speculated to exist between the VF model and the asphyxia model, we investigated whether vasopressin is also effective in a rat asphyxia model. Twenty-one Sprague-Dawley male rats were divided into three groups: vasopressin 0.8 U/kg (Vaso-Gr), epinephrine 0.05 mg/kg (Epi-Gr), and saline same volume as the other two drugs (Sal-Gr). Five minutes after suffocation induced by obstruction of the tracheal tube, CPR was performed using each drug. Although only one animal survived (17%) in the Sal-Gr, 6/7 (85%) survived in both Vaso-Gr and Epi-Gr (P<0.01). Vasopressin is as effective as epinephrine for CPR in asphyxia-induced rats.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11841890     DOI: 10.1016/s0300-9572(01)00447-6

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  3 in total

1.  Effect of vasopressin on hippocampal injury in a rodent model of asphyxial cardiopulmonary arrest.

Authors:  Nan Zhang; Xiu-Xian Zang; Ning Dong; Fang Liu; Shao-Kun Wang; H E Yan; DA-Hai Xu; Xiao-Liang Liu; L I Pang
Journal:  Exp Ther Med       Date:  2016-01-28       Impact factor: 2.447

2.  Landiolol, an ultra short acting beta1-blocker, improves pulmonary edema after cardiopulmonary resuscitation with epinephrine in rats.

Authors:  Masahiro Uraoka; Yoshiki Nakajima; Tadayoshi Kurita; Akira Suzuki; Kotaro Takata; Shigehito Sato
Journal:  J Anesth       Date:  2009-12-29       Impact factor: 2.078

3.  Vasopressin decreases neuronal apoptosis during cardiopulmonary resuscitation.

Authors:  Chi Ma; Zhe Zhu; Xu Wang; Gang Zhao; Xiaoliang Liu; Rui Li
Journal:  Neural Regen Res       Date:  2014-03-15       Impact factor: 5.135

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.